To amend the Federal Food, Drug, and Cosmetic Act to allow the sponsor of a drug to use a non-animal test as an alternative to an animal test for purposes of demonstrating the safety and effectiveness of a drug if such approach satisfies the requirements of the applicable statutes and regulations.
Animals for Regulatory Fairness Act of 2020 or the AARF Act of 2020
This bill requires the Food and Drug Administration to allow an applicant for approval to market a new drug to use a non-animal test to demonstrate the safety and effectiveness of the drug if the non-animal test satisfies all other applicable requirements.
Introduced in House
Introduced in House
Referred to the House Committee on Energy and Commerce.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line